| payload |
{"created_at":"2026-04-16T02:19:46.489 {"created_at":"2026-04-16T02:19:46.489462+00:00","dedupe_key":"signal_enriched:news_delta:115e113f5f670283","evidence_event_ids":["evt_501c0bffce86"],"signal_type":"news_headline_delta","source":"news_rss","value":{"aggregator_url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxNNFJkNDRsUS1meWRnd3lydFIxYTFCcmxsRUpzNnlmemhqZmg0Rk5FUVhMMlItYjhjS1F4MFZKOWR5OUxqWGZQUmFJNDJxR3BVcnBnaG1wOG9INFQ1WllYZEFESW00ZnFwbUNINnl2NnU5eUh5cERPVnF1NWRGdEUzLURGRXoxNXNSY21VaTQyUGFfN0l1SlE?oc=5","as_of":"2026-04-16T02:19:46.489462+00:00","canonical_url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.z46LtA-qfIg.L.X.O/am=GAIFAACAA2YBAwpA/d=1/ed=1/rs=ALs0n2PeUbKSDKfQ9Op-3wUE_8hlNgDpuA/m=syndicationarticleview,_b,_tp","enrichment":{"aggregator_url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxNNFJkNDRsUS1meWRnd3lydFIxYTFCcmxsRUpzNnlmemhqZmg0Rk5FUVhMMlItYjhjS1F4MFZKOWR5OUxqWGZQUmFJNDJxR3BVcnBnaG1wOG9INFQ1WllYZEFESW00ZnFwbUNINnl2NnU5eUh5cERPVnF1NWRGdEUzLURGRXoxNXNSY21VaTQyUGFfN0l1SlE?oc=5","article_chars":0,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_11bdab4e80dc799a","canonical_host":"gstatic.com","canonical_is_aggregator":true,"canonical_url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.z46LtA-qfIg.L.X.O/am=GAIFAACAA2YBAwpA/d=1/ed=1/rs=ALs0n2PeUbKSDKfQ9Op-3wUE_8hlNgDpuA/m=syndicationarticleview,_b,_tp","content_type":"text/html; charset=utf-8","enriched_at":"2026-04-16T02:48:08.278958+00:00","extraction_method":"none","fetched_description":"","fetched_title":"","final_url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxNNFJkNDRsUS1meWRnd3lydFIxYTFCcmxsRUpzNnlmemhqZmg0Rk5FUVhMMlItYjhjS1F4MFZKOWR5OUxqWGZQUmFJNDJxR3BVcnBnaG1wOG9INFQ1WllYZEFESW00ZnFwbUNINnl2NnU5eUh5cERPVnF1NWRGdEUzLURGRXoxNXNSY21VaTQyUGFfN0l1SlE?oc=5&hl=en-US&gl=US&ceid=US:en","html_truncated":true,"paywall_likely":false,"publisher_domain":"arstechnica.com","publisher_resolution":"payload_source_domain","requested_url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxNNFJkNDRsUS1meWRnd3lydFIxYTFCcmxsRUpzNnlmemhqZmg0Rk5FUVhMMlItYjhjS1F4MFZKOWR5OUxqWGZQUmFJNDJxR3BVcnBnaG1wOG9INFQ1WllYZEFESW00ZnFwbUNINnl2NnU5eUh5cERPVnF1NWRGdEUzLURGRXoxNXNSY21VaTQyUGFfN0l1SlE?oc=5","source_event_id":"evt_501c0bffce86","source_quality":"empty","status_code":200,"version":"signal_enrichment_v2"},"fp":"31e2798d5b44f780","published_at":"2026-04-15T14:11:02+00:00","publisher_domain":"arstechnica.com","signal_understanding":{"analysis_basis":"headline_and_summary","claim_confidence":0.42,"dates_mentioned":[],"entities":[],"event_type":"other","information_gaps":["article_text_unavailable"],"key_facts":["Headline: What\u2019s the deal with Alzheimer\u2019s disease and amyloid? - Ars Technica","Source summary: What\u2019s the deal with Alzheimer\u2019s disease and amyloid? Ars Technica Analysis of Alzheimer\u2019s Drugs Stirs Debate About Their Effectiveness The New York Times Alzheimer\u2019s Drugs Targeting Amyloid Don\u2019t Help, Review Finds Bloomberg.com Effect of \u2018gamechanger\u2019 Alzheimer\u2019s drugs \u2018trivial\u2019, review concludes The Guardian Scientists say we\u2019ve been treating Alzheimer\u2019s all wrong ScienceDaily"],"numeric_claims":[],"primary_claim":"What\u2019s the deal with Alzheimer\u2019s disease and amyloid? - Ars Technica","relevance_score":0.46,"sentiment":"neutral","source_quality":"unknown","summary":"What\u2019s the deal with Alzheimer\u2019s disease and amyloid? Ars Technica Analysis of Alzheimer\u2019s Drugs Stirs Debate About Their Effectiveness The New York Times Alzheimer\u2019s Drugs Targeting Amyloid Don\u2019t Help, Review Finds Bloomberg.com Effect of \u2018gamechanger\u2019 Alzheimer\u2019s drugs \u2018trivial\u2019, review concludes The Guardian Scientists say we\u2019ve been treating Alzheimer\u2019s all wrong ScienceDaily","topics":["news headline"]},"source":"Ars Technica","source_domain":"arstechnica.com","source_url":"https://arstechnica.com","summary":"What\u2019s the deal with Alzheimer\u2019s disease and amyloid? Ars Technica Analysis of Alzheimer\u2019s Drugs Stirs Debate About Their Effectiveness The New York Times Alzheimer\u2019s Drugs Targeting Amyloid Don\u2019t Help, Review Finds Bloomberg.com Effect of \u2018gamechanger\u2019 Alzheimer\u2019s drugs \u2018trivial\u2019, review concludes The Guardian Scientists say we\u2019ve been treating Alzheimer\u2019s all wrong ScienceDaily","title":"What\u2019s the deal with Alzheimer\u2019s disease and amyloid? - Ars Technica","url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.z46LtA-qfIg.L.X.O/am=GAIFAACAA2YBAwpA/d=1/ed=1/rs=ALs0n2PeUbKSDKfQ9Op-3wUE_8hlNgDpuA/m=syndicationarticleview,_b,_tp"}}... |